The Shotlee Journal
Browse Shotlee articles about GLP-1 Medications.
Showing 9 / 934 GLP-1 Medications articles
The U.S. military has spent nearly $726 million on GLP-1 medications since 2021. This article delves into the controversy surrounding this expenditure, examining the obesity crisis within the armed forces and the debate over these weight-loss drugs.
New research indicates a significant decline in bariatric surgeries, coinciding with the rise of GLP-1 medications. This article delves into the implications, comparing the efficacy and cost-effectiveness of these treatments and offering guidance for patients.
Recent findings suggest a connection between GLP-1 agonists and temporary hair shedding. Discover the science, risk factors, and how to manage this side effect while on weight loss therapy.
The rise of GLP-1 medications like semaglutide and tirzepatide has sparked a debate about their impact on the body positivity movement. Supermodel Ashley Graham shares her perspective on this evolving conversation.
Ricki Lake shares her successful 40-pound weight loss journey, achieved through a dedicated approach to diet, consistent exercise, and insightful self-monitoring, offering valuable lessons for those seeking sustainable health improvements.
New market data suggests a unique opportunity for protein-focused brands as GLP-1 therapies alter consumer eating habits. Learn how this shift affects your health strategy.
The rise of GLP-1 medications is creating unexpected challenges and adaptations in the wedding dress industry, as brides experience rapid weight loss that disrupts traditional timelines and fitting processes.
A growing number of state Medicaid programs are restricting or eliminating coverage for GLP-1 medications like Ozempic and Wegovy for obesity treatment due to budget constraints.
New research suggests that the effectiveness of popular GLP-1 weight loss medications may significantly diminish with intermittent use. Understand the implications for your health journey.
